SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-23-090027
Filing Date
2023-08-11
Accepted
2023-08-11 06:18:24
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2322443d3_defa14a.htm DEFA14A 10926
2 GRAPHIC tm2322443d3_defa14aimg001.jpg GRAPHIC 182172
3 GRAPHIC tm2322443d3_defa14aimg002.jpg GRAPHIC 55925
  Complete submission text file 0001104659-23-090027.txt   340330
Mailing Address 350 TECHNOLOGY DRIVE PITTSBURGH PA 15219
Business Address 350 TECHNOLOGY DRIVE PITTSBURGH PA 15219 412-763-3350
NeuBase Therapeutics, Inc. (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35963 | Film No.: 231161421
SIC: 2834 Pharmaceutical Preparations